Cited by 328Animal testing and alternativesNeuroscience and Neuropharmacology ResearchMemory and Neural Mechanisms

The DOI matches its Crossref record; 164 of the 167 references it cites were found in a registry or an index.

Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models

Open access

Markou, Athina, Chiamulera, Christian, Geyer, Mark A, Tricklebank, Mark, Steckler, Thomas·2009·Neuropsychopharmacology

DOI 10.1038/npp.2008.173PMC PMC2651739

Open this paper in CoChat — free account Open PDF

Abstract

Despite great advances in basic neuroscience knowledge, the improved understanding of brain functioning has not yet led to the introduction of truly novel pharmacological approaches to the treatment of central nervous system (CNS) disorders. This situation has been partly attributed to the difficulty of predicting efficacy in patients based on results from preclinical studies. To address these issues, this review critically discusses the traditional role of animal models in drug discovery, the difficulties encountered, and the reasons why this approach has led to suboptimal utilization of the information animal models provide. The discussion focuses on how animal models can contribute most effectively to translational medicine and drug discovery and the changes needed to increase the probability of achieving clinical benefit. Emphasis is placed on the need to improve the flow of information from the clinical/human domain to the preclinical domain and the benefits of using truly translational measures in both preclinical and clinical testing. Few would dispute the need to move away from the concept of modeling CNS diseases in their entirety using animals. However, the current emphasis on specific dimensions of psychopathology that can be objectively assessed in both clinical populations and animal models has not yet provided concrete examples of successful preclinical-clinical translation in CNS drug discovery. The purpose of this review is to strongly encourage ever more intensive clinical and preclinical interactions to ensure that basic science knowledge gained from improved animal models with good predictive and construct validity readily becomes available to the pharmaceutical industry and clinical researchers to benefit patients as quickly as possible.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/npp.2008.173

Cites

164 of 164 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Construct validity in psychological tests.
Cronbach, L. J., & Meehl, P. E. (1955) · Psychological Bulletin · doi:10.1037/h0040957 · Cited by 11,195
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
Schildkraut, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,568
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
The druggable genome
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Behavioural despair in rats: A new model sensitive to antidepressant treatments
Porsolt, R. D., Anton, G., Blavet, N., & Jalfre, M. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90118-8 · Cited by 3,138
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904

Flagged first, then by citations

Show all 167 references

3 of the 167 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Bilder RM, Lieberman JA, Kim Y, Alvir JM, Reiter G (1992). Methylphenidate and neuroleptic effects on oral word production in schizophrenia. Neuropsychiatry Neuropsychol Behav Neurol 5: 262–271.
Horowski R, Sastre-y-Hernandez M (1985). Clinical effects of neurotropic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: global evaluation of the preliminary reports. Curr Ther Res 38: 23–29.
Murray Law B (2007). What's ahead for rimonabant?. Doc News 4: 10–13.

Sorted by citations

An anatomically comprehensive atlas of the adult human brain transcriptome
Hawrylycz, M. J., Lein, E. S., Guillozet-Bongaarts, A. L., Shen, E. H., Ng, L., Miller, J. A., van de Lagemaat, L. N., Smith, K. A., Ebbert, A., Riley, Z. L., et al. (2012) · Nature · doi:10.1038/nature11405 · Cited by 3,083
Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023
Conserved cell types with divergent features in human versus mouse cortex
Hodge, R. D., Bakken, T. E., Miller, J. A., Smith, K. A., Barkan, E. R., Graybuck, L. T., Close, J. L., Long, B., Johansen, N., Penn, O., et al. (2019) · Nature · doi:10.1038/s41586-019-1506-7 · Cited by 1,775
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citation
The neurobiology of anhedonia and other reward-related deficits
Der-Avakian, A., & Markou, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.005 · Cited by 1,130
Self-citation
Animal models of human disease: challenges in enabling translation
McGonigle, P., & Ruggeri, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.006 · Cited by 610
The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis
Scofield, M. D., Heinsbroek, J. A., Gipson, C. D., Kupchik, Y. M., Spencer, S., Smith, A. C. W., Roberts-Wolfe, D., & Kalivas, P. W. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012484 · Cited by 598
Water associated zero maze: a novel rat test for long term traumatic re-experiencing
Ritov, G., & Richter‐Levin, G. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00001 · Cited by 580
Measuring thigmotaxis in larval zebrafish
Schnörr, S. J., Steenbergen, P. J., Richardson, M. K., & Champagne, D. L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.016 · Cited by 492
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 405
Translating rodent behavioral repertoire to zebrafish (Danio rerio): Relevance for stress research
Champagne, D. L., Hoefnagels, C. C. M., de Kloet, E. R., & Richardson, M. K. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.06.001 · Cited by 398
The age of anxiety: role of animal models of anxiolytic action in drug discovery
Cryan, J. F., & Sweeney, F. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01362.x · Cited by 327
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia
Young, J. W., Powell, S. B., Risbrough, V. B., Marston, H. M., & Geyer, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.004 · Cited by 312
Self-citation
Spontaneous Gamma Activity in Schizophrenia
Hirano, Y., Oribe, N., Kanba, S., Onitsuka, T., Nestor, P. G., & Spencer, K. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2642 · Cited by 274
The touchscreen operant platform for assessing executive function in rats and mice
Mar, A. C., Horner, A. E., Nilsson, S. R. O., Alsiö, J., Kent, B. A., Kim, C. H., Holmes, A., Saksida, L. M., & Bussey, T. J. (2013) · Nature Protocols · doi:10.1038/nprot.2013.123 · Cited by 271
Helplessness: A systematic translational review of theory and evidence for its relevance to understanding and treating depression
Pryce, C. R., Azzinnari, D., Spinelli, S., Seifritz, E., Tegethoff, M., & Meinlschmidt, G. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.006 · Cited by 259
Methamphetamine-Associated Psychosis
Grant, K. M., LeVan, T. D., Wells, S. M., Li, M., Stoltenberg, S. F., Gendelman, H. E., Carlo, G., & Bevins, R. A. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9288-1 · Cited by 235
3D in vitro modeling of the central nervous system
Hopkins, A. M., DeSimone, E. K., Chwalek, K., & Kaplan, D. L. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.11.003 · Cited by 234
Patterns of avoidance behaviours in the light/dark preference test in young juvenile zebrafish: A pharmacological study
Steenbergen, P. J., Richardson, M. K., & Champagne, D. L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.025 · Cited by 235
Animal Models of Neuropsychiatric Disorders
Fernando, A. B. P., & Robbins, T. W. (2011) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032210-104454 · Cited by 223
A Reverse-Translational Study of Dysfunctional Exploration in Psychiatric Disorders
Perry, W., Minassian, A., Paulus, M. P., Young, J. W., Kincaid, M. J., Ferguson, E. J., Henry, B. L., Zhuang, X., Masten, V. L., Sharp, R. F., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.58 · Cited by 200
Self-citation
The use of the zebrafish model in stress research
Steenbergen, P. J., Richardson, M. K., & Champagne, D. L. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.10.010 · Cited by 208
The 5-Choice Continuous Performance Test: Evidence for a Translational Test of Vigilance for Mice
Young, J. W., Light, G. A., Marston, H. M., Sharp, R. F., & Geyer, M. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004227 · Cited by 189
Self-citation
Identifying fast-onset antidepressants using rodent models
Ramaker, M. J., & Dulawa, S. C. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.36 · Cited by 183
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis
Stephenson, D. T., O'Neill, S. M., Narayan, S., Tiwari, A., Arnold, E., Samaroo, H. D., Du, F., Ring, R. H., Campbell, B., Pletcher, M., et al. (2011) · Molecular Autism · doi:10.1186/2040-2392-2-7 · Cited by 180
Irritable bowel syndrome: towards biomarker identification
Clarke, G. A., Quigley, E. M. M., Cryan, J. F., & Dinan, T. G. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.08.001 · Cited by 181
Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression
Zink, M., Vollmayr, B., Gebicke-Haerter, P. J., & Henn, F. A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.09.005 · Cited by 177
Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics
Kazdoba, T. M., Leach, P. T., Yang, M., Silverman, J. L., Solomon, M., & Crawley, J. N. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5003 · Cited by 185
Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment
Ashare, R. L., Falcone, M., & Lerman, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.034 · Cited by 170
Circadian rhythms and depression: Human psychopathology and animal models
Kronfeld-Schor, N., & Einat, H. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.020 · Cited by 166
Assessing learning and memory in pigs
Gieling, E. T., Nordquist, R. E., & van der Staay, F. J. (2011) · Animal Cognition · doi:10.1007/s10071-010-0364-3 · Cited by 154
Mapping anhedonia-specific dysfunction in a transdiagnostic approach: an ALE meta-analysis
Zhang, B., Lin, P., Shi, H., Öngür, D., Auerbach, R. P., Wang, X., Yao, S., & Wang, X. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-015-9457-6 · Cited by 152
Economic demand predicts addiction-like behavior and therapeutic efficacy of oxytocin in the rat
Bentzley, B. S., Jhou, T. C., & Aston‐Jones, G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406324111 · Cited by 151
New Insights into Toxicity and Drug Testing
Gowder, S. J. (2013) · InTech eBooks · doi:10.5772/55886 · Cited by 149
The Free-movement pattern Y-maze: A cross-species measure of working memory and executive function
Cleal, M., Fontana, B. D., Ranson, D. C., McBride, S. D., Swinny, J. D., Redhead, E. S., & Parker, M. O. (2020) · Behavior Research Methods · doi:10.3758/s13428-020-01452-x · Cited by 159
Rodent tests of depression and anxiety: Construct validity and translational relevance
Gencturk, S., & Ünal, G. (2024) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-024-01171-2 · Cited by 160
The lonely mouse: Verification of a separation-induced model of depression in female mice
Martin, A. L., & Brown, R. E. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.10.006 · Cited by 158
Translating cognition from animals to humans
Keeler, J. F., & Robbins, T. W. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.028 · Cited by 137
Translational assessment of reward and motivational deficits in psychiatric disorders
Der-Avakian, A., Barnes, S. A., Markou, A., & Pizzagalli, D. A. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5004 · Cited by 122
Self-citation
Learning from the past and looking to the future: emerging perspectives for improving the treatment of psychiatric disorders
Millan, M. J., Goodwin, G. M., Meyer-Lindenberg, A., & Ove Ögren, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.016 · Cited by 132
Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits
D’Souza, M. S., & Markou, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.044 · Cited by 121
Self-citation
Developing treatments for cognitive deficits in schizophrenia: The challenge of translation
Young, J. W., & Geyer, M. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114555252 · Cited by 110
Self-citation
Modelling depression in animals: at the interface of reward and stress pathways
Slattery, D. A., & Cryan, J. F. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4552-6 · Cited by 120
Mouse social stress induces increased fear conditioning, helplessness and fatigue to physical challenge together with markers of altered immune and dopamine function
Azzinnari, D., Sigrist, H., Staehli, S., Palme, R., Hildebrandt, T., Leparc, G., Hengerer, B., Seifritz, E., & Pryce, C. R. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.039 · Cited by 110
Developmental rodent models of fear and anxiety: from neurobiology to pharmacology
Ganella, D. E., & Kim, J. H. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12643 · Cited by 107
Neural Substrates of Psychostimulant Withdrawal-Induced Anhedonia
D’Souza, M. S., & Markou, A. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_20 · Cited by 108
Self-citation
Innovative Drugs to Treat Depression: Did Animal Models Fail to Be Predictive or Did Clinical Trials Fail to Detect Effects?
Belzung, C. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.342 · Cited by 106
Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer’s Disease: What are the Roadblocks and How Can They Be Overcome?
Banik, A., Brown, R. E., Bamburg, J., Lahiri, D. K., Khurana, D., Friedland, R. P., Chen, W., Ding, Y., Mudher, A., Padjen, A. L., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150136 · Cited by 102
Neuroimaging in Psychiatric Disorders
Masdeu, J. C. (2011) · Neurotherapeutics · doi:10.1007/s13311-010-0006-0 · Cited by 106
Assessment of reward responsiveness in the response bias probabilistic reward task in rats: implications for cross-species translational research
Der-Avakian, A., D'Souza, M. S., Pizzagalli, D. A., & Markou, A. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.74 · Cited by 100
Self-citation
Behavioral Indices in Antipsychotic Drug Discovery
Porsolt, R. D., Moser, P. C., & Castagné, V. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166710 · Cited by 101
Challenges in the Search for Drugs to Treat Central Nervous System Disorders
Enna, S. J., & Williams, M. C. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143420 · Cited by 100
A novel 3D method of locomotor analysis in adult zebrafish: Implications for automated detection of CNS drug-evoked phenotypes
Stewart, A., Grieco, F., Tegelenbosch, R. A. J., Kyzar, E. J., Nguyen, M., Kaluyeva, A. A., Song, C., Noldus, L. P. J. J., & Kalueff, A. V. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.07.023 · Cited by 100
Social stress models in depression research: what do they tell us?
Chaouloff, F. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1606-x · Cited by 112
Behavioral profiling as a translational approach in an animal model of posttraumatic stress disorder
Ardi, Z., Albrecht, A., Richter-Levin, A., Saha, R., & Richter‐Levin, G. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.012 · Cited by 90
The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey
Smith, S. M., Uslaner, J. M., Cox, C. D., Huszar, S. L., Cannon, C. E., Vardigan, J. D., Eddins, D. M., Toolan, D. M., Kandebo, M., Yao, L., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.013 · Cited by 84
The Ups and Downs of Modelling Mood Disorders in Rodents
Slattery, D. A., & Cryan, J. F. (2014) · ILAR Journal · doi:10.1093/ilar/ilu026 · Cited by 92
Association Between Nicotine Withdrawal and Reward Responsiveness in Humans and Rats
Pergadia, M. L., Der‐Avakian, A., D’Souza, M. S., Madden, P. A. F., Heath, A. C., Shiffman, S. M., Markou, A., & Pizzagalli, D. A. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1016 · Cited by 90
Self-citation
Schedule-induced polydipsia as a model of compulsive behavior: neuropharmacological and neuroendocrine bases
Moreno, M., & Flores, P. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2570-3 · Cited by 85
Transgenic mouse models for ADHD
Leo, D., & Gainetdinov, R. R. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1639-1 · Cited by 86
Toward the explainability, transparency, and universality of machine learning for behavioral classification in neuroscience
Goodwin, N. L., Nilsson, S. R. O., Choong, J. J., & Golden, S. A. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102544 · Cited by 85
Developing highER-throughput zebrafish screens for in-vivo CNS drug discovery
Stewart, A., Gerlai, R. T., & Kalueff, A. V. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00014 · Cited by 82
Measuring the construct of executive control in schizophrenia: Defining and validating translational animal paradigms for discovery research
Gilmour, G., Arguello, P. A., Bari, A., Brown, V. J., Carter, C., Floresco, S., Jentsch, J. D., Tait, D. S., Young, J. W., & Robbins, T. W. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.04.006 · Cited by 81
How Many Ways Can Mouse Behavioral Experiments Go Wrong? Confounding Variables in Mouse Models of Neurodegenerative Diseases and How to Control Them
Schellinck, H. M., Cyr, D. P., & Brown, R. E. (2010) · Advances in the study of behavior · doi:10.1016/s0065-3454(10)41007-4 · Cited by 80
The effectiveness of multi-target agents in schizophrenia and mood disorders: Relevance of receptor signature to clinical action
Wong, E. H. F., Tarazi, F. I., & Shahid, M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.001 · Cited by 78
Measuring behavior of animal models: faults and remedies
Fonio, E., Golani, I., & Benjamini, Y. (2012) · Nature Methods · doi:10.1038/nmeth.2252 · Cited by 81
Validating Animal Models for Preclinical Research: A Scientific and Ethical Discussion
Varga, O., Hansen, A. K., Sandøe, P., & Olsson, I. A. S. (2010) · Alternatives to Laboratory Animals · doi:10.1177/026119291003800309 · Cited by 74
CRISPR/Cas9-mediated disruption of SHANK3 in monkey leads to drug-treatable autism-like symptoms
Tu, Z., Zhao, H., Li, B., Yan, S., Wang, L., Tang, Y., Li, Z., Bai, D., Li, C., Lin, Y., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy367 · Cited by 73
Future Directions for Research in Autism Spectrum Disorders
Damiano, C. R., Mazefsky, C. A., White, S. W., & Dichter, G. S. (2014) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2014.945214 · Cited by 86
Are animal models of addiction useful?
Field, M., & Kersbergen, I. (2019) · Addiction · doi:10.1111/add.14764 · Cited by 69
Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property
Higgins, G. A., Carroll, N. K., Brown, M., MacMillan, C., Silenieks, L. B., Thevarkunnel, S., Izhakova, J., Magomedova, L., DeLannoy, I., & Sellers, E. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.640241 · Cited by 72
Encore: Behavioural animal models of stress, depression and mood disorders
Petković, A., & Chaudhury, D. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.931964 · Cited by 74
Investigating the mechanism(s) underlying switching between states in bipolar disorder
Young, J. W., & Dulcis, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.019 · Cited by 68
Oxytocin and Rodent Models of Addiction
Leong, K.-C., Cox, S. S., King, C. E., Becker, H. C., & Reichel, C. M. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.007 · Cited by 72
Haloperidol‐induced catalepsy as an animal model for parkinsonism: A systematic review of experimental studies
Waku, I., Magalhães, M. S., Alves, C. D. O., & de Oliveira, A. R. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15222 · Cited by 67
Short-term social isolation induces depressive-like behaviour and reinstates the retrieval of an aversive task: mood-congruent memory in male mice?
Takatsu-Coleman, A. L., Patti, C. L., Zanin, K. A., Zager, A., Carvalho, R. C., Borçoi, A. R., Ceccon, L. M. B., Berro, L. F., Tufik, S., Andersen, M. L., et al. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.120050 · Cited by 66
Stress and glucocorticoid receptor transcriptional programming in time and space: Implications for the brain–gut axis
Wiley, J. W., Higgins, G. A., & Athey, B. D. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12706 · Cited by 66
Preclinical Behavioral Models for Predicting Antipsychotic Activity
Castagné, V., Moser, P. C., & Porsolt, R. D. (2009) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)57010-4 · Cited by 64
Relaxin’ the brain: a case for targeting the nucleus incertus network and relaxin‐3/RXFP3 system in neuropsychiatric disorders
Kumar, J. R., Rajkumar, R., Jayakody, T., Marwari, S., Hóng, J., Ma, S., Gundlach, A. L., Lai, M. K. P., & Dawe, G. S. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13564 · Cited by 63
Relationship between effortful motivation and neurocognition in schizophrenia
Bismark, A. W., Thomas, M. L., Tarasenko, M. A., Shiluk, A. L., Rackelmann, S. Y., Young, J. W., & Light, G. A. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.06.042 · Cited by 63
Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy
Grace, P. M., Loram, L. C., Christianson, J. P., Strand, K. A., Flyer-Adams, J. G., Penzkover, K. R., Forsayeth, J., van Dam, A., Mahoney, M. J., Maier, S. F., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.012 · Cited by 62
The role of fMRI in drug development
Carmichael, O. T., Schwarz, A. J., Chatham, C. H., Scott, D., Turner, J. A., Upadhyay, J., Coimbra, A., Goodman, J. A., Baumgartner, R., English, B. A., et al. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.11.012 · Cited by 60
5-hydroxytryptamine 2C receptors in the dorsal striatum mediate stress-induced interference with negatively reinforced instrumental escape behavior
Strong, P. V., Christianson, J. P., Loughridge, A. B., Amat, J., Maier, S. F., Fleshner, M., & Greenwood, B. N. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.041 · Cited by 61
Using zebrafish (Danio rerio) models to understand the critical role of social interactions in mental health and wellbeing
Fontana, B. D., Müller, T. E., Cleal, M., de Abreu, M. S., Norton, W., Demin, K. A., Amstislavskaya, T. G., Petersen, E. V., Kalueff, A. V., Parker, M. O., et al. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.101993 · Cited by 60
The translational study of apathy—an ecological approach
Cathomas, F., Hartmann-Riemer, M. N., Seifritz, E., Pryce, C. R., & Kaiser, S. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00241 · Cited by 61
Anhedonia, avolition, and anticipatory deficits: Assessments in animals with relevance to the negative symptoms of schizophrenia
Barnes, S. A., Der‐Avakian, A., & Markou, A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.10.001 · Cited by 65
Self-citation
The failure of the antidepressant drug discovery process is systemic
Hendrie, C. A., & Pickles, A. R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112466185 · Cited by 60
Lost in Translation: Neuropsychiatric Drug Development
Becker, R. E., & Greig, N. H. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000446 · Cited by 56
CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease)
Eaton, S. L., Proudfoot, C., Lillico, S. G., Skehel, P., Kline, R., Hamer, K., Rzechorzek, N. M., Clutton, E. R., Gregson, R., King, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45859-9 · Cited by 55
Caution When Diagnosing Your Mouse With Schizophrenia: The Use and Misuse of Model Animals for Understanding Psychiatric Disorders
Wong, A. H. C., & Josselyn, S. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.023 · Cited by 58
Animal models of tic disorders: A translational perspective
Godar, S. C., Mosher, L. J., Giovanni, G. D., & Bortolato, M. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.09.008 · Cited by 55
The role of translational bioinformatics in drug discovery
Buchan, N. S., Rajpal, D. K., Webster, Y., Alatorre, C., Gudivada, R. C., Zheng, C., Sanséau, P., & Koehler, J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.03.002 · Cited by 57
Negative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic Window
Mihov, Y., & Hasler, G. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw002 · Cited by 56
The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders
Cocks, G. D., Curran, S. R., Gami‐Patel, P., Uwanogho, D., Jeffries, A. R., Kathuria, A., Lucchesi, W., Wood, V. H. J., Dixon, R., Ogilvie, C. M., et al. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3196-4 · Cited by 49
Self-citation
Novel positive allosteric modulators of GABAA receptors: Do subtle differences in activity at α1 plus α5 versus α2 plus α3 subunits account for dissimilarities in behavioral effects in rats?
Savić, M. M., Majumder, S., Huang, S., Edwankar, R. V., Furtmüller, R., Joksimovic, S. M., Clayton, T., Ramerstorfer, J., Milinković, M. M., Roth, B. L., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.01.004 · Cited by 51
Putative cognitive enhancers in preclinical models related to schizophrenia: The search for an elusive target
Barak, S., & Weiner, I. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.011 · Cited by 51
Interoception and Learning: Import to Understanding and Treating Diseases and Psychopathologies
Bevins, R. A., & Besheer, J. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5001028 · Cited by 49
Recent Progress in the Synthesis and Characterization of Group II Metabotropic Glutamate Receptor Allosteric Modulators
Sheffler, D. J., Pinkerton, A. B., Dahl, R. S., Markou, A., & Cosford, N. D. P. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200008d · Cited by 49
Self-citation
Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System
Srinivas, N., Maffuid, K., & Kashuba, A. D. M. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0632-y · Cited by 49
Touchscreen cognitive testing: Cross-species translation and co-clinical trials in neurodegenerative and neuropsychiatric disease
Palmer, D. D., Dumont, J. R., Dexter, T. D., Prado, M. A. M., Finger, E. C., Bussey, T. J., & Saksida, L. M. (2021) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2021.107443 · Cited by 54

Authors: Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T.
Affiliations: University of California San Diego (US)
Eli Lilly (United Kingdom) (GB)
Corresponding author: Markou, Athina
ORCID: Geyer, Mark A
Tricklebank, Mark
Steckler, Thomas
Venue: Neuropsychopharmacology
Publisher: Springer Science and Business Media LLC
Published: 2008-10-01
Volume: 34
Issue: 1
Pages: 74-89
ISSN: 0893-133X (ISSN-L)
1740-634X
DOI: 10.1038/npp.2008.173
PMC: PMC2651739
OpenAlex: W2142885788
Cited by: 328
References: 167
Citations by year: 2026: 6 · 2025: 14 · 2024: 10 · 2023: 8 · 2022: 8 · 2021: 14 · 2020: 12 · 2019: 14 · 2018: 18 · 2017: 16 · 2016: 15 · 2015: 30 · 2014: 28 · 2013: 27 · 2012: 35
FWCI: 6.32
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Neuropsychopharmacology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Department of Veterans Affairs
Tobacco-Related Disease Research Program
National Institutes of Health
National Institute of Mental Health (U01 MH 69062, 5R01MH52885, R01MH071916, U01MH069062, R01MH052885, R01MH062527)
National Institute on Drug Abuse (R01DA023926, R56DA011946, R01DA002925, 2R01DA11946, R01DA023209, 5R01 DA02925, R01DA011946)
NIH Clinical Center
Topics: Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
Keywords: animal models, CNS drug discovery, translational medicine, predictive validity, construct validity, central nervous system disorders, psychopathology, clinical trials, preclinical drug testing
MeSH terms: Animals, Central Nervous System Diseases, Clinical Trials as Topic, Disease Models, Animal, Drug Evaluation, Preclinical, Forecasting, Humans, Neurosciences, Reproducibility of Results, Models, Animal, Biomarkers, Pharmacological, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks